Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-15 4:17 pm Purchase |
2024-07-03 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
VIKING GLOBAL INVESTORS LP | 1,752,656 5.200% |
1,752,656 (New Position) |
Filing History |
| 2024-06-18 5:05 pm Sale |
2024-06-17 | 13G | APi Group Corporation APG |
VIKING GLOBAL INVESTORS LP | 27,032,516 9.900% |
-4,990,399 (-15.58%) |
Filing History |
| 2024-06-07 4:23 pm Purchase |
2024-05-29 | 13G | Inhibrx Biosciences, Inc. INBX |
VIKING GLOBAL INVESTORS LP | 1,787,705 12.300% |
1,787,705 (New Position) |
Filing History |
| 2024-06-03 5:56 pm Sale |
2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-7,150,826 (Position Closed) |
Filing History |
| 2024-03-20 6:05 pm Purchase |
2024-03-18 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 58,651,170 15.300% |
29,544,805 (+101.51%) |
Filing History |
| 2024-03-01 4:18 pm Sale |
2024-02-28 | 13G | APi Group Corporation APG |
VIKING GLOBAL INVESTORS LP | 32,022,915 12.300% |
-10,494,242 (-24.68%) |
Filing History |
| 2024-02-28 4:28 pm Sale |
2024-02-26 | 13G | RayzeBio, Inc. Common Stock RYZB |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-6,642,700 (Position Closed) |
Filing History |
| 2024-02-14 10:27 am Purchase |
2023-12-31 | 13G | Pharvaris N.V. PHVS |
VIKING GLOBAL INVESTORS LP | 3,656,923 7.000% |
425,000 (+13.15%) |
Filing History |
| 2024-02-14 10:26 am Purchase |
2023-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
VIKING GLOBAL INVESTORS LP | 6,159,146 9.700% |
1,750,000 (+39.69%) |
Filing History |
| 2024-02-14 10:25 am Purchase |
2023-12-31 | 13G | APi Group Corporation APG |
VIKING GLOBAL INVESTORS LP | 42,517,157 17.400% |
421,364 (+1.00%) |
Filing History |
| 2024-02-14 10:24 am Sale |
2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
VIKING GLOBAL INVESTORS LP | 2,962,555 4.400% |
-1,672,051 (-36.08%) |
Filing History |
| 2024-02-14 10:23 am Unchanged |
2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
VIKING GLOBAL INVESTORS LP | 29,993,708 20.700% |
0 (Unchanged) |
Filing History |
| 2024-02-14 10:21 am Purchase |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
VIKING GLOBAL INVESTORS LP | 6,599,062 9.990% |
436,700 (+7.09%) |
Filing History |
| 2024-02-14 10:20 am Sale |
2023-12-31 | 13G | Roivant Sciences Ltd. ROIV |
VIKING GLOBAL INVESTORS LP | 69,368,961 8.600% |
-5,869,739 (-7.80%) |
Filing History |
| 2024-02-14 10:18 am Unchanged |
2023-12-31 | 13G | Rallybio Corporation RLYB |
VIKING GLOBAL INVESTORS LP | 4,194,777 11.100% |
0 (Unchanged) |
Filing History |
| 2024-02-14 10:17 am Sale |
2023-12-31 | 13G | PepGen Inc. PEPG |
VIKING GLOBAL INVESTORS LP | 1,482,434 6.200% |
-62,197 (-4.03%) |
Filing History |
| 2024-02-14 10:16 am Unchanged |
2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
VIKING GLOBAL INVESTORS LP | 3,577,128 8.800% |
0 (Unchanged) |
Filing History |
| 2024-02-14 10:15 am Sale |
2023-12-31 | 13G | Valvoline Inc. VVV |
VIKING GLOBAL INVESTORS LP | 3,176,309 2.400% |
-5,162,147 (-61.91%) |
Filing History |
| 2024-02-14 10:13 am Sale |
2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
VIKING GLOBAL INVESTORS LP | 5,145,112 5.100% |
-713,420 (-12.18%) |
Filing History |
| 2024-02-14 10:12 am Purchase |
2023-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 8,024,565 9.700% |
1,500,000 (+22.99%) |
Filing History |